Cargando…

Impact of examined lymph node count on long-term survival of T1-2N0M0 double primary NSCLC patients after surgery: a SEER study

PURPOSE: The relationship between examined lymph nodes (ELN) and survival has been confirmed in several single early-stage malignancies. We studied the association between the ELN count and the long-term survival of T1-2N0M0 double primary non-small cell lung cancer (DP-NSCLC) patients after surgery...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Kan, Zhi, Xiaohui, Shen, Yue, Ma, Yuanyuan, Su, Xinyu, Zhou, Liqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049255/
https://www.ncbi.nlm.nih.gov/pubmed/32149032
http://dx.doi.org/10.7717/peerj.8692
_version_ 1783502404344348672
author Jiang, Kan
Zhi, Xiaohui
Shen, Yue
Ma, Yuanyuan
Su, Xinyu
Zhou, Liqing
author_facet Jiang, Kan
Zhi, Xiaohui
Shen, Yue
Ma, Yuanyuan
Su, Xinyu
Zhou, Liqing
author_sort Jiang, Kan
collection PubMed
description PURPOSE: The relationship between examined lymph nodes (ELN) and survival has been confirmed in several single early-stage malignancies. We studied the association between the ELN count and the long-term survival of T1-2N0M0 double primary non-small cell lung cancer (DP-NSCLC) patients after surgery, based on the Surveillance, Epidemiology and End Results (SEER) database. METHODS: A total of 948 patients were identified and their independent prognostic factors were analyzed. These factors included the ELN count, which related to overall survival (OS) and the cancer-specific survival (CSS) of synchronous (n = 426) and metachronous (n = 522) T1-2N0M0 DP-NSCLC patients after surgery. RESULTS: X-tile analysis indicated that the cutoff value for the sum of ELNs was 22 for both OS and CSS in the synchronous DP-NSCLC group. Patients with a sum of ELNs >22 were statistically more likely to survive than those with ≤22 ELNs. X-tile analysis revealed that the ELN count of the second lesion was related to both OS and CSS in the metachronous DP-NSCLC group. The optimal cutoff value was nine. These results were confirmed using univariate and multivariate Cox regression analyses. CONCLUSION: Our findings indicate that ELN count was highly correlated with the long-term survival of T1-2N0M0 double primary NSCLC patients after surgery.
format Online
Article
Text
id pubmed-7049255
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-70492552020-03-06 Impact of examined lymph node count on long-term survival of T1-2N0M0 double primary NSCLC patients after surgery: a SEER study Jiang, Kan Zhi, Xiaohui Shen, Yue Ma, Yuanyuan Su, Xinyu Zhou, Liqing PeerJ Diabetes and Endocrinology PURPOSE: The relationship between examined lymph nodes (ELN) and survival has been confirmed in several single early-stage malignancies. We studied the association between the ELN count and the long-term survival of T1-2N0M0 double primary non-small cell lung cancer (DP-NSCLC) patients after surgery, based on the Surveillance, Epidemiology and End Results (SEER) database. METHODS: A total of 948 patients were identified and their independent prognostic factors were analyzed. These factors included the ELN count, which related to overall survival (OS) and the cancer-specific survival (CSS) of synchronous (n = 426) and metachronous (n = 522) T1-2N0M0 DP-NSCLC patients after surgery. RESULTS: X-tile analysis indicated that the cutoff value for the sum of ELNs was 22 for both OS and CSS in the synchronous DP-NSCLC group. Patients with a sum of ELNs >22 were statistically more likely to survive than those with ≤22 ELNs. X-tile analysis revealed that the ELN count of the second lesion was related to both OS and CSS in the metachronous DP-NSCLC group. The optimal cutoff value was nine. These results were confirmed using univariate and multivariate Cox regression analyses. CONCLUSION: Our findings indicate that ELN count was highly correlated with the long-term survival of T1-2N0M0 double primary NSCLC patients after surgery. PeerJ Inc. 2020-02-26 /pmc/articles/PMC7049255/ /pubmed/32149032 http://dx.doi.org/10.7717/peerj.8692 Text en © 2020 Jiang et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Diabetes and Endocrinology
Jiang, Kan
Zhi, Xiaohui
Shen, Yue
Ma, Yuanyuan
Su, Xinyu
Zhou, Liqing
Impact of examined lymph node count on long-term survival of T1-2N0M0 double primary NSCLC patients after surgery: a SEER study
title Impact of examined lymph node count on long-term survival of T1-2N0M0 double primary NSCLC patients after surgery: a SEER study
title_full Impact of examined lymph node count on long-term survival of T1-2N0M0 double primary NSCLC patients after surgery: a SEER study
title_fullStr Impact of examined lymph node count on long-term survival of T1-2N0M0 double primary NSCLC patients after surgery: a SEER study
title_full_unstemmed Impact of examined lymph node count on long-term survival of T1-2N0M0 double primary NSCLC patients after surgery: a SEER study
title_short Impact of examined lymph node count on long-term survival of T1-2N0M0 double primary NSCLC patients after surgery: a SEER study
title_sort impact of examined lymph node count on long-term survival of t1-2n0m0 double primary nsclc patients after surgery: a seer study
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049255/
https://www.ncbi.nlm.nih.gov/pubmed/32149032
http://dx.doi.org/10.7717/peerj.8692
work_keys_str_mv AT jiangkan impactofexaminedlymphnodecountonlongtermsurvivaloft12n0m0doubleprimarynsclcpatientsaftersurgeryaseerstudy
AT zhixiaohui impactofexaminedlymphnodecountonlongtermsurvivaloft12n0m0doubleprimarynsclcpatientsaftersurgeryaseerstudy
AT shenyue impactofexaminedlymphnodecountonlongtermsurvivaloft12n0m0doubleprimarynsclcpatientsaftersurgeryaseerstudy
AT mayuanyuan impactofexaminedlymphnodecountonlongtermsurvivaloft12n0m0doubleprimarynsclcpatientsaftersurgeryaseerstudy
AT suxinyu impactofexaminedlymphnodecountonlongtermsurvivaloft12n0m0doubleprimarynsclcpatientsaftersurgeryaseerstudy
AT zhouliqing impactofexaminedlymphnodecountonlongtermsurvivaloft12n0m0doubleprimarynsclcpatientsaftersurgeryaseerstudy